CNBC just announced: “Pfizer CEO says it will be able to deliver Seagen’s cancer therapy at a scale not seen before with $43 billion deal” (click here)
Seagen is a “leading developer” of medicine called antibody-drug conjugates, or ADCs, which are designed to kill cancer cells and spare healthy ones. ADCs use antibodies to deliver small molecule drugs directly to a tumor site, which may reduce side effects and offer greater efficacy, according to Seagen’s website.
What is Seagen’s Cancer treatment?
Sounds about right for Pfizer. But this warning is straight from Seagen’s website.
First, this is nothing like mRNA. These are monoclonal antibodies carrying cytotoxic drug molecules to tumor receptors; once they bind they get internalized into the tumor cell, release the cytotoxic compound which halts cell replication and instructs the cell to die (apoptosis). It sounds good in theory and it has been tried (unsuccessfully) many times before.
It’s important to stress that this is not a new tech…
Watch with a 7-day free trial
Subscribe to COVID Intel - by Dr.William Makis to watch this video and get 7 days of free access to the full post archives.
